BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haapasalo K, Meri S. Regulation of the Complement System by Pentraxins. Front Immunol 2019;10:1750. [PMID: 31428091 DOI: 10.3389/fimmu.2019.01750] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Chang X, Li D, Liu C, Zhang Z, Wang T. Pentraxin 3 is a diagnostic and prognostic marker for ovarian epithelial cancer patients based on comprehensive bioinformatics and experiments. Cancer Cell Int 2021;21:193. [PMID: 33952272 DOI: 10.1186/s12935-021-01854-7] [Reference Citation Analysis]
2 Schvarcz CA, Danics L, Krenács T, Viana P, Béres R, Vancsik T, Nagy Á, Gyenesei A, Kun J, Fonović M, Vidmar R, Benyó Z, Kaucsár T, Hamar P. Modulated Electro-Hyperthermia Induces a Prominent Local Stress Response and Growth Inhibition in Mouse Breast Cancer Isografts. Cancers (Basel) 2021;13:1744. [PMID: 33917524 DOI: 10.3390/cancers13071744] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Conticini E, Hellmich B, Frediani B, Csernok E, Löffler C. Utility of serum complement factors C3 and C4 as biomarkers during therapeutic management of giant cell arteritis. Scand J Rheumatol 2022;:1-7. [PMID: 35383517 DOI: 10.1080/03009742.2022.2047311] [Reference Citation Analysis]
4 Yu N, Hu Y, Cui H, Cheng L, Chen X. Evaluating pentraxin-3 and hypersensitivity CRP expression in obese pregnancies. Taiwan J Obstet Gynecol 2021;60:816-20. [PMID: 34507654 DOI: 10.1016/j.tjog.2021.07.006] [Reference Citation Analysis]
5 Meri S, Haapasalo K. Function and Dysfunction of Complement Factor H During Formation of Lipid-Rich Deposits. Front Immunol 2020;11:611830. [PMID: 33363547 DOI: 10.3389/fimmu.2020.611830] [Reference Citation Analysis]
6 Carr JM, Cabezas-Falcon S, Dubowsky JG, Hulme-Jones J, Gordon DL. Dengue virus and the complement alternative pathway. FEBS Lett 2020;594:2543-55. [PMID: 31943152 DOI: 10.1002/1873-3468.13730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Sheriff A, Kayser S, Brunner P, Vogt B. C-Reactive Protein Triggers Cell Death in Ischemic Cells. Front Immunol 2021;12:630430. [PMID: 33679775 DOI: 10.3389/fimmu.2021.630430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kerget F, Kerget B, Kahraman ÇY, Araz Ö, Akgün M, Uçar EY, Sağlam L. Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19. J Med Virol 2021. [PMID: 34314051 DOI: 10.1002/jmv.27238] [Reference Citation Analysis]
9 Urban A, Kowalska D, Stasiłojć G, Kuźniewska A, Skrobińska A, Arjona E, Alonso EC, Fenollosa Segarra MÁ, Jongerius I, Spaapen R, Satchell S, Thiel M, Ołdziej S, Rodriguez de Córdoba S, Okrój M. Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein. Front Immunol 2021;12:724361. [PMID: 34899688 DOI: 10.3389/fimmu.2021.724361] [Reference Citation Analysis]
10 Labarrere CA, Kassab GS. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses. Front Immunol 2021;12:652252. [PMID: 34630377 DOI: 10.3389/fimmu.2021.652252] [Reference Citation Analysis]
11 Riesbeck K. Complement evasion by the human respiratory tract pathogens Haemophilus influenzae and Moraxella catarrhalis. FEBS Lett 2020;594:2586-97. [PMID: 32053211 DOI: 10.1002/1873-3468.13758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
12 Park S, Lee YJ, Kim YW, Ko J, Park JH, Kim IH, Kim HJ, Oh D, Park BS. Atypical Hemolytic Uremic Syndrome (p.Gly1110Ala) with Autoimmune Disease. Am J Case Rep 2020;21:e922567. [PMID: 32361709 DOI: 10.12659/AJCR.922567] [Reference Citation Analysis]
13 Angeli F, Angeli E, Trapasso M, Verdecchia P. Pentraxin-3 and the pathogenesis of preeclampsia. Hypertens Res 2020;43:979-81. [DOI: 10.1038/s41440-020-0466-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Parente R, Possetti V, Erreni M, D'Autilia F, Bottazzi B, Garlanda C, Mantovani A, Inforzato A, Doni A. Complementary Roles of Short and Long Pentraxins in the Complement-Mediated Immune Response to Aspergillus fumigatus Infections. Front Immunol 2021;12:785883. [PMID: 34868070 DOI: 10.3389/fimmu.2021.785883] [Reference Citation Analysis]
15 Chen Y, Sun W, Tang H, Li Y, Li C, Wang L, Chen J, Lin W, Li S, Fan Z, Cheng Y, Chen C. Interactions Between Immunomodulatory Biomaterials and Immune Microenvironment: Cues for Immunomodulation Strategies in Tissue Repair. Front Bioeng Biotechnol 2022;10:820940. [DOI: 10.3389/fbioe.2022.820940] [Reference Citation Analysis]
16 Kárpáti É, Papp A, Schneider AE, Hajnal D, Cserhalmi M, Csincsi ÁI, Uzonyi B, Józsi M. Interaction of the Factor H Family Proteins FHR-1 and FHR-5 With DNA and Dead Cells: Implications for the Regulation of Complement Activation and Opsonization. Front Immunol 2020;11:1297. [PMID: 32765490 DOI: 10.3389/fimmu.2020.01297] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Correa N, Arbildi P, Rosano S, López V, Rodríguez-camejo C, Colistro V, Zubiaurre V, Cora M, Sosa L, Hernández A, Sóñora C. Predictive value of blood measurement of Complement System proteins and metabolic components for early detection of obstetric complications linked to poor placental function. Placenta 2020;101:45-8. [DOI: 10.1016/j.placenta.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kovács RÁ, Vadászi H, Bulyáki É, Török G, Tóth V, Mátyás D, Kun J, Hunyadi-Gulyás É, Fedor FZ, Csincsi Á, Medzihradszky K, Homolya L, Juhász G, Kékesi KA, Józsi M, Györffy BA, Kardos J. Identification of Neuronal Pentraxins as Synaptic Binding Partners of C1q and the Involvement of NP1 in Synaptic Pruning in Adult Mice. Front Immunol 2020;11:599771. [PMID: 33628204 DOI: 10.3389/fimmu.2020.599771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Du H, Hu H, Wang P, Wang X, Zhang Y, Jiang H, Li J, Bai X, Lian J. Predictive value of pentraxin-3 on disease severity and mortality risk in patients with hemorrhagic fever with renal syndrome. BMC Infect Dis 2021;21:445. [PMID: 34001041 DOI: 10.1186/s12879-021-06145-0] [Reference Citation Analysis]
20 Sobuś A, Baumert B, Gołąb-Janowska M, Kulig P, Paczkowska E, Łuczkowska K, Rogińska D, Zawiślak A, Milczarek S, Osękowska B, Pawlukowska W, Meller A, Machowska-Sempruch K, Wełnicka A, Nowacki P, Machaliński B. Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients. J Clin Med 2021;10:5251. [PMID: 34830531 DOI: 10.3390/jcm10225251] [Reference Citation Analysis]
21 Divella C, Stasi A, Franzin R, Rossini M, Pontrelli P, Sallustio F, Netti GS, Ranieri E, Lacitignola L, Staffieri F, Crovace AM, Lucarelli G, Ditonno P, Battaglia M, Daha MR, van der Pol P, van Kooten C, Grandaliano G, Gesualdo L, Stallone G, Castellano G. Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury. Aging (Albany NY) 2021;13:10920-33. [PMID: 33875620 DOI: 10.18632/aging.202992] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Parente R, Doni A, Bottazzi B, Garlanda C, Inforzato A. The complement system in Aspergillus fumigatus infections and its crosstalk with pentraxins. FEBS Lett 2020;594:2480-501. [PMID: 31994174 DOI: 10.1002/1873-3468.13744] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
23 Singh SK, Ngwa DN, Agrawal A. Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection. Front Immunol 2020;11:1812. [PMID: 32903624 DOI: 10.3389/fimmu.2020.01812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Yaman B, Kumbaracı BS, Gómez González CA, Akalın T, Şen S. C4d as a Practical Marker for Cutaneous Amyloidosis. Am J Dermatopathol 2022;44:28-32. [PMID: 34889811 DOI: 10.1097/DAD.0000000000002057] [Reference Citation Analysis]
25 Schmitt HM, Fehrman RL, Maes ME, Yang H, Guo LW, Schlamp CL, Pelzel HR, Nickells RW. Increased Susceptibility and Intrinsic Apoptotic Signaling in Neurons by Induced HDAC3 Expression. Invest Ophthalmol Vis Sci 2021;62:14. [PMID: 34398198 DOI: 10.1167/iovs.62.10.14] [Reference Citation Analysis]
26 Funk-hilsdorf TC, Behrens F, Grune J, Simmons S. Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer. Front Physiol 2022;13:819145. [DOI: 10.3389/fphys.2022.819145] [Reference Citation Analysis]